Ecopipam Shows Promise for Tourette Syndrome in Young People
Episode Summary
A randomized pediatric trial found ecopipam reduced Tourette syndrome tic severity versus placebo, supporting further investigation while long-term safety, comparative effectiveness, and FDA approval remain unresolved.